Nevro surges on Senza approvable letter from FDA

Nevro shares surge on news of its receipt of an 'approvable letter' from the FDA for its Senza spinal cord stimulator for chronic pain.

Food & Drug Administration (FDA), Nevro Corp.

News Well, Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AYWWn6